中国医药
中國醫藥
중국의약
CHINA MEDICINE
2014年
8期
1129-1132
,共4页
哮喘%老年人%吸入用布地奈德混悬液%氨茶碱
哮喘%老年人%吸入用佈地奈德混懸液%氨茶堿
효천%노년인%흡입용포지내덕혼현액%안다감
Asthma%The elderly%Budesonide suspension for inhalation%Aminophylline
目的 观察吸入用布地奈德混悬液联合氨茶碱治疗老年支气管哮喘的临床效果.方法 将广东省东莞市人民医院诊治的80例老年支气管哮喘患者按随机数字表分为对照组与试验组,每组40例.对照组在支持治疗基础上给予2 mg吸入用布地奈德混悬液溶于5 ml的0.9％氯化钠注射液中雾化吸入,2次/d;试验组在对照组治疗基础上给予250 mg氨茶碱溶于100 ml 0.9％氯化钠注射液中静脉滴注,2次/d;均1周为1个疗程,治疗2个疗程.对比分析2组患者的治疗效果.结果 试验组临床有效率为97.5％ (39/40),对照组为87.5％ (35/40),试验组有效率明显高于对照组,差异有统计学意义(P＜0.05).2组各出现2例不良反应,但程度较低,均可以忍受,2组不良反应发生率均为5.0％,差异无统计学意义(P＞0.05).结论 使用吸入用布地奈德混悬液联合氨茶碱对老年支气管哮喘患者进行治疗,疗效满意,不良反应发生率较低.
目的 觀察吸入用佈地奈德混懸液聯閤氨茶堿治療老年支氣管哮喘的臨床效果.方法 將廣東省東莞市人民醫院診治的80例老年支氣管哮喘患者按隨機數字錶分為對照組與試驗組,每組40例.對照組在支持治療基礎上給予2 mg吸入用佈地奈德混懸液溶于5 ml的0.9％氯化鈉註射液中霧化吸入,2次/d;試驗組在對照組治療基礎上給予250 mg氨茶堿溶于100 ml 0.9％氯化鈉註射液中靜脈滴註,2次/d;均1週為1箇療程,治療2箇療程.對比分析2組患者的治療效果.結果 試驗組臨床有效率為97.5％ (39/40),對照組為87.5％ (35/40),試驗組有效率明顯高于對照組,差異有統計學意義(P＜0.05).2組各齣現2例不良反應,但程度較低,均可以忍受,2組不良反應髮生率均為5.0％,差異無統計學意義(P＞0.05).結論 使用吸入用佈地奈德混懸液聯閤氨茶堿對老年支氣管哮喘患者進行治療,療效滿意,不良反應髮生率較低.
목적 관찰흡입용포지내덕혼현액연합안다감치료노년지기관효천적림상효과.방법 장광동성동완시인민의원진치적80례노년지기관효천환자안수궤수자표분위대조조여시험조,매조40례.대조조재지지치료기출상급여2 mg흡입용포지내덕혼현액용우5 ml적0.9％록화납주사액중무화흡입,2차/d;시험조재대조조치료기출상급여250 mg안다감용우100 ml 0.9％록화납주사액중정맥적주,2차/d;균1주위1개료정,치료2개료정.대비분석2조환자적치료효과.결과 시험조림상유효솔위97.5％ (39/40),대조조위87.5％ (35/40),시험조유효솔명현고우대조조,차이유통계학의의(P＜0.05).2조각출현2례불량반응,단정도교저,균가이인수,2조불량반응발생솔균위5.0％,차이무통계학의의(P＞0.05).결론 사용흡입용포지내덕혼현액연합안다감대노년지기관효천환자진행치료,료효만의,불량반응발생솔교저.
Objective To observe clinical effects of budesonide suspension for inhalation and aminophylline in treatment of senile bronchial asthma.Methods Eighty cases with bronchial asthma were randomly assigned to control group and experimental group ; each group had 40 cases.The control group was given 2 mg budesonide suspension for inhalation dissolved in 5 ml 0.9％ sodium chloride injection saline ; experimental group was given aminophylline 250 mg dissolved in 100 ml normal saline 0.9％ sodium chloride injection based on the treatment of the control group.The therapeutic effect was compared between two groups.Results The effective rate in the experimental group (97.5％,39/40) was significantly higher than that in the control group(87.5％,35/40) (P ＜ 0.05).There were two cases in each group had adverse symptoms and the incidence of adverse reactions in two groups was 5.0％ (P ＞ 0.05).Conclusion The combined use of budesonide suspension for inhalation and aminophylline in treatment of elderly patients with bronchial asthma has excellent efficacy and low incidence of adverse reactions.
